Roche wins Japan approval for personalized cancer drug Rozlytrek

Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalized medicines that require a biomarker test to identify prospective patients.